Objective: In this study, we aimed at investigating the effect of placing hyaluronate-carboxymethylcellulose membrane (HCMC) on the formation of adhesion postoperatively in a damaged area in the peritoneum of the anterior stomach wall. Methods: The study was conducted on 30 rabbits. A transverse peritoneal damage was infl icted on the stomach anterior walls of all rabbits. In the fi rst treatment group, HCMC was placed on the sutured anterior wall of stomach of 15 rabbits. In the second control group, on the other hand, no treatment was conducted on 15 rabbits. On the 30th day after the operation, relaparatomy was performed on the rabbits and adhesions were evaluated by an independent surgeon according to seriousness and prevalence scores. Results: There were postoperative adhesions (POA) in 12 (80 %) rabbits in the control group. On the other hand, there were POA in 5 rabbits (33.3 %) in the treatment group. In the treatment group, adhesion was totally prevalent in 2 rabbits (13.3 %), whereas this ratio was 7 (46.6 %) in the control group (p < 0.01).
Abdominal adhesions are a frequently observed complication of open and laparoscopic surgery. Especially general surgeons and gynecologists frequently encounter postoperative adhesions (POA) following an intraabdominal surgery. The incidence of POA was reported to be 93 % in upper abdominal surgeries and 67-93 % in lower abdominal surgeries (1) . We believe that efforts aimed at preventing adhesions can be improved when the process of recovery of peritoneum is better understood (2) . The most appropriate adhesion prevention efforts are the ones made within the fi rst seven days, when the peritoneum recovery process is faster (3) .
Many barrier agents have been tried in recent years to prevent POAs, but very few of them have proven to be effective and reliable. These are Interceed® (oxidized regenerated cellulose), Seprafi lm® (HA-CMC) and Goretex surgical membrane® (expanded polytetra-fl uoroethylene). Seprafi lm® (HA-CMC) is one of the most widely used. Seprafi lm® began to be used worldwide after it was approved by the FDA in 1996. HA-CMC membrane turns into gel form within 24-48 hours of its application and is reabsorbed where it was applied by the 7th day (14) . Radioactive studies indicate that it takes the body 28 days to become rid of Seprafi lm® (4) .
The aim of this study was to evaluate the effectiveness of Seprafi lm in prevention of POA.
Material and methods
This study was conducted on 30 New Zealand type rabbits of both sexes, each with an average weight of 1,625 gr. The study was performed in accordance with the principles of "Helsinki Universal Animal Rights Declaration". The rabbits, which were fed standard pellet feed and tap water, were left unary for 6 hours before the surgical intervention. The subjects were divided into the two groups, namely the treatment group and the control group, each with 15 members. All of the subjects were anesthetized during spontaneous breathing, through intramuscular injection on the hind leg's upper thigh, using 50 mg/kg ketamine hydrochloride (Ketalar-Parke Davis®) and 10 mg/kg Xylazin (Xylazine® -20 injection, Butle Company, Columbus, OH). After the abdomen was shaved, the skin was cleaned with betadine and the abdomen was entered with a 10 cm midline incision in sterile conditions. The stomach was revealed, and then damage was infl icted on the peritoneum with a 3 cm transverse incision on the visceral peritoneum of the anterior stomach wall. An effort was made to create suture ischemia and a foreign object reaction, using 4 / 0 atraumatic silk suture on the damaged peritoneum with intervals of 0.5 cm (Fig. 1) . Before the abdomens of the 15 subjects in the treatment group were recovered, the sutured stomach front wall was covered with 6 x 3 cm Seprafi lm® (Genzym Corporation, MA) extending beyond the damaged area by 1 cm on all sides, and thus the damaged area was separated physically from the anterior abdominan wall and the other intraabdominal organs (Fig. 2) . Seprafi lm® was not applied to the control group. The abdomen was covered with 3 / 0 silk suture. The incision was cleaned with betadine and left open. The rabbits began to be fed standard feed and water in the 6th hour after the surgery. The abdomens were entered on the 30th day of the surgery through the previous incision using the same anesthetic method, and the adhesions that formed on the anterior stomach wall were scored by an independent surgeon on the basis of prevalence and seriousness (Tab. 1) (5).
Statistics
In the statistical analysis, SPSS 15.0 for Windows was used. For the comparison of the presence and the seriousness of adhesions, chi-square test was used. The p value lower than 0.05 was considered to be statistically signifi cant.
Results
Adhesions were observed in 12 (80 %) of the 15 rabbits in the control group, whereas adhesions were observed in only 5 (33.3 %) of the 15 rabbits in the treatment group. This difference was statistically signifi cant (p < 0.05). Cohesive vascular adhesion was not seen in the treatment group, while it was seen in 3 (20 %) of the control group (p < 0.01) (Fig. 3) . No statistically signifi cant difference was found between the formation of fi lmy avascular adhesion in the treatment group, where Seprafi lm® was used, and the formation of fi lmy avascular adhesion in the control group (Tab. 2). While there was an intensive vascular or avascular adhesion in 8 (53 %) of the control group, it was present in only 3 (20 %) of the treatment group (p < 0.05). Adhesion was totally prevalent in 7 (46.6 %) rabbits of the control group, whereas this Tab. 3. Distribution of adhesion prevalence score.
fi gure was 2 (13.3 %) in the treatment group (p < 0.01) (Fig. 3) . Prevalence of adhesion in the treatment group had decreased signifi cantly. There was no signifi cant difference between the two groups in the prevalence 1 and 2 scores (Tab. 3).
Discussion
Intraabdominal adhesions occur between the areas where the surface of the peritoneum is damaged and usually between the greater omentum and stomach wall (1) (2) (3) (4) (5) (6) . While very few of those who have undergone a surgery suffer from the symptoms related to postoperative adhesions (POA) (7), all gastrointestinal surgeons encounter patients with POAs in their daily lives (7) . Are POAs really a problem? Ellis et al investigated problems arising from POAs in order to fi nd an answer to this question in 1999 (8) . In America, more than 400,000 surgical interventions are performed every year to treat POA complications, and this costs about 1.3 million dollars annually (3). Adhesion related complications account for 30 % of the patients who were hospitalized again after a colorectal surgery (6) . In a survey conducted by Scott Combes et al among general surgeons it was found that 76 % of the surgeons performed 2 interventions due to POA, while 31 % of them conducted more than 5 interventions (9). Peritoneal adhesions are the underlying cause of 32 % of acute intestinal obstructions and of 65-75 % of small bowel obstructions. This complication accounts for 2.6-3.3 % of all indications for laparotomy (10) . POA development risk can be signifi cantly reduced if the surgeon complies with microsurgical principles. These principles include delicate tissue manipulation, total hemostasis, little or nonreactive suture and minimum use of electrocautery (11) . More time is spent to enter the peritoneum cavity in patients with POA who have undergone a surgical intervention previously (12) .
Implementation of a good surgical technique seems to be the best way of reducing POAs to a minimum. These techniques can be listed as minimum tissue trauma, total hemostasis, avoiding ischemia, preventing excessive drying of intra-abdominal organs, avoiding infection and making sure that there are no remains of foreign objects (13) . Ischemia is one of the most prevalent results leading to POA. Laparoscopic cholecystectomies, where mono-polar and ultrasonic energy, a leading cause of ischemia, are used, were compared in terms of postoperative pain, duration of stay in hospital and time spent before a return to work. Fewer infl ammatory responses and fewer POA formations were observed in patients on whom ultrasonic energy was used (14) . Previous adhesions recurred in about 66 % of the patients, on whom adhesiolysis was performed, using methods such as electrocautery, sharp dissection, CO 2 , Argon and KTP laser, but new adhesions developed in 12 % of them (15) . The questions pertaining to what the factors that affect the formation of adhesions are (direct and indirect clinical results of POAs and surgical technical measures), still remain to be answered (16) . It is frequently reported in the relevant literature that POAs lead to serious morbidity. While the rate of POA was 75-95 % in laparotomy, it was found to be 12-40 % in laparoscopy. The number of new adhesions after laparoscopic adhesiolysis was found to be signifi cantly lower than adhesions that formed after adesiolysis was performed with laparotomy (15) . In experiments on animals and volunteering patients, Seprafi lm® was used in surgeries that required a second look laparotomy, and POAs decreased signifi cantly (17) . In studies that used Seprafi lm®, reliability of the studies was increased by omitting those that used agents such as corticosteroids, salicylates and heparin, all of which affect the formation of adhesions. The results of the study were evaluated by independent surgeons and recorded on video. It is important that the area where Seprafi lm® is applied is suffi ciently dry, hemostasis is performed well and there is no space left between Seprafi lm® and the tissue (18) . One study suggested that treatment and control groups should be observed for at least 10 years in order to better evaluate POA related small intestine obstructions (15) . In a period of over 10 years, Seprafi lm® use saves 383 dollars for the patient and 1122 dollars for each patient socioeconomically (19) . The fact that Seprafi lm® is thin and easily wrinkles, causes diffi culty in application, especially in abdomens that are hard to recover, and in small incisions (20) . The ideal adhesion barrier should meet the following criteria: (1) it should separate tissues effectively; (21) it should have a half-life that is long enough to stay in peritoneum for the critical 7 day period, which is the time for peritoneum to heal; (7) it should be absorbed and metabolized without triggering an obvious infl ammatory tissue response; (8) it should stay effective and active when there is blood in the environment; (3) it should not interrupt healing of the scar; (22) and it should not contribute to bacterial increase (3). In conclusion, Seprafi lm® use reduces the rate of POA signifi cantly when there are ischemic, damaged and foreign objects. The rules (which have accumulated since the emergence of surgery constitute surgical principles and require painstaking and aesthetic work) are still maintained to be the most important in the prevention of POA.
